Umbilical cord blood not suitable for assessing allergy risk
Allergies occur when the defence mechanisms of the immune system malfunction and misread normal substances entering the body as invading pathogens. Antibodies are part of our biochemical arsenal for combating viruses, bacteria, parasites and other alien substances, but during an allergic reaction the antibody, known as IgE, is directed against usually harmless substances such as grass pollen, nuts, pets or eggs. Asthma and allergies are chronic diseases that reduce quality of life and pose an economic burden on society. New parents have therefore previously been asked if they would like hospitals to assess the risk their babies run of developing allergies in childhood. Hospitals tests the risk by measuring the amount of IgE in the blood of the umbilical cord. The results are then used to determine the need for allergy prophylaxis, e.g. whether babies need a special allergy-friendly milk substitute. The biomarker originates from the mother
However, researchers from COPSAC (Copenhagen Studies on Asthma in Childhood) at the Faculty of Health Sciences, University of Copenhagen recently discovered indications that IgE in the blood of the umbilical cord could originate from the mother, and decided to conduct a focused study on this.
They measured the total amount if IgE in the blood of the umbilical cord in 243 new-borns. The researchers subsequently determined how much IgE originated from the mother by using hypersensitive analyses of IgE in the blood of the umbilical cord, blood from the mother, and blood from the baby six months after birth.
"We discovered that approximately half of the tests with increased IgE levels in the umbilical blood were due to IgE from the mother," Dr. Klaus Bønnelykke, PhD says. "This may explain why many studies have showed poor results from the use of umbilical cord IgE. In future, if we want to use blood from the umbilical cord for to assess the risk of an infant developing asthma or allergy we need to take the transfer of IgE from the mother into account. Or we will need to find another method."
The discovery has been published in the Journal of Allergy and Clinical Immunology.
Source: University of Copenhagen
- Cutting the cord to determine babies' health risk from toxic exposureWed, 3 Dec 2008, 18:50:58 EST
- New blood test for newborns to detect allergy riskFri, 21 May 2010, 10:15:21 EDT
- Survey: Few physicians support private banking of umbilical cord bloodFri, 6 Mar 2009, 13:46:05 EST
- U of M researchers find 2 units of umbilical cord blood reduce risk of leukemia recurrenceFri, 13 Nov 2009, 18:44:36 EST
- New technology enhances therapeutic potential of cord blood stem cellsFri, 6 Jun 2008, 11:15:42 EDT
- Umbilical cord blood not suitable for assessing allergy riskfrom Science CentricWed, 6 Oct 2010, 1:10:27 EDT
- Umbilical cord blood not suitable for assessing allergy riskfrom Science DailyTue, 5 Oct 2010, 14:30:35 EDT
- Umbilical cord blood not suitable for assessing allergy riskfrom Science BlogTue, 5 Oct 2010, 11:30:26 EDT
- Umbilical cord blood not suitable for assessing allergy riskfrom PhysorgTue, 5 Oct 2010, 10:00:45 EDT
Latest Science NewsletterGet the latest and most popular science news articles of the week in your Inbox! It's free!
Check out our next project, Biology.Net
From other science news sites
Popular science news articles
- UC Davis engineers create on-wetting fabric drains sweat
- Not just blowing in the wind: Compressing air for renewable energy storage
- Amazon River exhales virtually all carbon taken up by rain forest
- 1 in 10 teens using 'study drugs,' but parents aren't paying attention
- Slow earthquakes: It's all in the rock mechanics
No popular news yet
No popular news yet
- Stem cell transplant restores memory, learning in mice
- 2 landmark studies report on success of using image-guided brachytherapy to treat cervical cancer
- Researchers discover mushrooms can provide as much vitamin D as supplements
- Cutting back on sleep harms blood vessel function and breathing control
- Study: Low-dose aspirin stymies proliferation of 2 breast cancer lines